Jill Weissberg-Benchell1, Danielle Hessler2, William H Polonsky3, Lawrence Fisher2. 1. Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA jwbenchell@luriechildrens.org. 2. Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA, USA. 3. Behavioral Diabetes Institute, Del Mar, CA, USA.
Abstract
BACKGROUND: The psychosocial impact of the bionic pancreas (BP) was assessed among children attending diabetes camp. METHODS:Nineteen children were randomly assigned for 5 days to the BP condition and 5 days to the control condition in a crossover design. RESULTS: Significant reductions in hypoglycemic fear and regimen burden were found. Children felt less burdened or worried about diabetes and felt freer to do things they enjoyed while using the BP. Children wished the BP responded to out of range numbers faster and expressed annoyance about carrying around the necessary equipment. CONCLUSIONS: Children may experience improved psychosocial outcomes following use of BP while expressing key areas of user concern. Future studies in less controlled environments with larger sample sizes can determine if these findings are generalizable to other groups.
RCT Entities:
BACKGROUND: The psychosocial impact of the bionic pancreas (BP) was assessed among children attending diabetes camp. METHODS: Nineteen children were randomly assigned for 5 days to the BP condition and 5 days to the control condition in a crossover design. RESULTS: Significant reductions in hypoglycemic fear and regimen burden were found. Children felt less burdened or worried about diabetes and felt freer to do things they enjoyed while using the BP. Children wished the BP responded to out of range numbers faster and expressed annoyance about carrying around the necessary equipment. CONCLUSIONS:Children may experience improved psychosocial outcomes following use of BP while expressing key areas of user concern. Future studies in less controlled environments with larger sample sizes can determine if these findings are generalizable to other groups.
Authors: Trang T Ly; Anirban Roy; Benyamin Grosman; John Shin; Alex Campbell; Salman Monirabbasi; Bradley Liang; Rie von Eyben; Satya Shanmugham; Paula Clinton; Bruce A Buckingham Journal: Diabetes Care Date: 2015-06-06 Impact factor: 19.112
Authors: Firas H El-Khatib; Steven J Russell; David M Nathan; Robert G Sutherlin; Edward R Damiano Journal: Sci Transl Med Date: 2010-04-14 Impact factor: 17.956
Authors: Marc Breton; Anne Farret; Daniela Bruttomesso; Stacey Anderson; Lalo Magni; Stephen Patek; Chiara Dalla Man; Jerome Place; Susan Demartini; Simone Del Favero; Chiara Toffanin; Colleen Hughes-Karvetski; Eyal Dassau; Howard Zisser; Francis J Doyle; Giuseppe De Nicolao; Angelo Avogaro; Claudio Cobelli; Eric Renard; Boris Kovatchev Journal: Diabetes Date: 2012-06-11 Impact factor: 9.461
Authors: Hood Thabit; Alexandra Lubina-Solomon; Marietta Stadler; Lalantha Leelarathna; Emma Walkinshaw; Andrew Pernet; Janet M Allen; Ahmed Iqbal; Pratik Choudhary; Kavita Kumareswaran; Marianna Nodale; Chloe Nisbet; Malgorzata E Wilinska; Katharine D Barnard; David B Dunger; Simon R Heller; Stephanie A Amiel; Mark L Evans; Roman Hovorka Journal: Lancet Diabetes Endocrinol Date: 2014-06-16 Impact factor: 32.069
Authors: Trang T Ly; Marc D Breton; Patrick Keith-Hynes; Daniel De Salvo; Paula Clinton; Kari Benassi; Benton Mize; Daniel Chernavvsky; Jéróme Place; Darrell M Wilson; Boris P Kovatchev; Bruce A Buckingham Journal: Diabetes Care Date: 2014-05-30 Impact factor: 19.112
Authors: Katarina Braune; Rayhan A Lal; Lenka Petruželková; Gary Scheiner; Per Winterdijk; Signe Schmidt; Linda Raimond; Korey K Hood; Michael C Riddell; Timothy C Skinner; Klemens Raile; Sufyan Hussain Journal: Lancet Diabetes Endocrinol Date: 2021-11-13 Impact factor: 32.069
Authors: Alessandro Bisio; Stacey Anderson; Lisa Norlander; Grenye O'Malley; Jessica Robic; Selassie Ogyaadu; Liana Hsu; Camilla Levister; Laya Ekhlaspour; David W Lam; Carol Levy; Bruce Buckingham; Marc D Breton Journal: Diabetes Care Date: 2022-01-01 Impact factor: 17.152
Authors: Gregory P Forlenza; Dan Raghinaru; Faye Cameron; B Wayne Bequette; H Peter Chase; R Paul Wadwa; David M Maahs; Emily Jost; Trang T Ly; Darrell M Wilson; Lisa Norlander; Laya Ekhlaspour; Hyojin Min; Paula Clinton; Nelly Njeru; John W Lum; Craig Kollman; Roy W Beck; Bruce A Buckingham Journal: Pediatr Diabetes Date: 2017-11-20 Impact factor: 4.866
Authors: Cari Berget; Laurel H Messer; Tim Vigers; Brigitte I Frohnert; Laura Pyle; R Paul Wadwa; Kimberly A Driscoll; Gregory P Forlenza Journal: Pediatr Diabetes Date: 2020-01-07 Impact factor: 4.866
Authors: Alessandro Bisio; Linda Gonder-Frederick; Ryan McFadden; Daniel Cherñavvsky; Mary Voelmle; Michael Pajewski; Pearl Yu; Heather Bonner; Sue A Brown Journal: J Diabetes Sci Technol Date: 2021-01-15
Authors: Yogish C Kudva; Lori M Laffel; Sue A Brown; Dan Raghinaru; Jordan E Pinsker; Laya Ekhlaspour; Carol J Levy; Laurel H Messer; Boris P Kovatchev; John W Lum; Roy W Beck; Linda Gonder-Frederick Journal: Diabetes Technol Ther Date: 2021-10 Impact factor: 7.337
Authors: Marc D Breton; Daniel R Cherñavvsky; Gregory P Forlenza; Mark D DeBoer; Jessica Robic; R Paul Wadwa; Laurel H Messer; Boris P Kovatchev; David M Maahs Journal: Diabetes Care Date: 2017-08-30 Impact factor: 19.112